Difference between revisions of "Paralytic"
Jump to navigation
Jump to search
Mfrdmanager (talk | contribs) (Created page with "==Section 8 - MEDICATION GUIDELINES== ===8.18 PARALYTIC=== ====Succinycholine==== '''DESCRIPTION''' * A skeletal muscle relaxant for intravenous (IV) administration indicate...") |
Mfrdmanager (talk | contribs) (→Succinycholine) |
||
| Line 11: | Line 11: | ||
* Do not administer to patients with Hx of HYPERKALEMIA, RHABDOMYOLYSIS, Severe Burns and Malignant hyperthermia. (i.e. peaked T waves, kidney insufficiency, renal failure, acidosis, crush injuries.) | * Do not administer to patients with Hx of HYPERKALEMIA, RHABDOMYOLYSIS, Severe Burns and Malignant hyperthermia. (i.e. peaked T waves, kidney insufficiency, renal failure, acidosis, crush injuries.) | ||
'''DOSAGE''' | '''DOSAGE''' | ||
| − | * | + | * 1.5 mg/kg intravenously (IV) for 1 dose |
* Maintenance for Prolonged Procedures - 0.04-0.07 mg/kg intravenously (IV) every 5-10 minutes as needed | * Maintenance for Prolonged Procedures - 0.04-0.07 mg/kg intravenously (IV) every 5-10 minutes as needed | ||
[[Category:Medication Guidelines|0819]] | [[Category:Medication Guidelines|0819]] | ||
Latest revision as of 07:10, 13 September 2019
Section 8 - MEDICATION GUIDELINES
8.18 PARALYTIC
Succinycholine
DESCRIPTION
- A skeletal muscle relaxant for intravenous (IV) administration indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.
INDICATIONS
CONTRAINDICATIONS
- Do not administer to patients with Hx of HYPERKALEMIA, RHABDOMYOLYSIS, Severe Burns and Malignant hyperthermia. (i.e. peaked T waves, kidney insufficiency, renal failure, acidosis, crush injuries.)
DOSAGE
- 1.5 mg/kg intravenously (IV) for 1 dose
- Maintenance for Prolonged Procedures - 0.04-0.07 mg/kg intravenously (IV) every 5-10 minutes as needed
